FreeGuest Editorial When “safe and effective” is not “reasonable and necessary”We can curb excessive drug dosing and improve the quality of cancer care January 16, 2026Vol.52 No.02By Mark J. Ratain and David A. Hyman
Guest Editorial With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025 December 19, 2025Vol.51 No.46By Richard J. Jones
Guest Editorial Mail-out colorectal cancer screening programs extend, rather than replace, clinical care December 05, 2025Vol.51 No.44By Paul J. Limburg
Guest Editorial My introduction to, and lessons learned from, Rick Pazdur November 21, 2025Vol.51 No.43By Mikkael A. Sekeres
Guest Editorial Rick Pazdur’s CDER appointment comes at exactly the right moment for FDA November 14, 2025Vol.51 No.42By Ellen V. Sigal
Guest Editorial How George Tidmarsh crossed the FDA-industry Rubicon November 07, 2025Vol.51 No.41By Mikkael A. Sekeres
Guest Editorial How next generation sequencing is powering the shift to more accessible—and comprehensive—cancer care November 07, 2025Vol.51 No.41By Kathy Davy
Guest Editorial Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding October 17, 2025Vol.51 No.38By Todd Burus, Caree McAfee and Pamela C. Hull
Guest Editorial ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology October 10, 2025Vol.51 No.37By Clifford A. Hudis and Thomas Kurian
Guest Editorial Lazarex Cancer Foundation set to close its doors Dec. 31Can health nonprofits survive in the current environment? October 10, 2025Vol.51 No.37By Erin Miller
